FDA NDC Directory · JSON-LD · Markdown

Zepbound

NDC 0002-6210 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nametirzepatide
Labeler / ManufacturerEli Lilly and Company
Marketing categoryNew Drug Application (innovator) · App NDA217806
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsTIRZEPATIDE (12.5 mg/mL)
Marketing started20260107
Package count1

External sources

Source: openFDA. Public-domain (CC0).